phrykt

Viatris (VTRS) share buybacks: $500M

Viatris spent $500M buying back its own shares in the year ended Dec 31, 2025, up 100.2% from $250M a year earlier.

From Viatris's filings with the SEC · Read the filing · VTRS stock page

Viatris share buybacks by year

$250M2023$250M2024$500M2025

#361 of 1,890 US companies by share buybacks · See the full ranking

Year endedShare buybacksChange
Dec 31, 2025$500M+100%
Dec 31, 2024$250MNo change
Dec 31, 2023$250M–

Share buybacks of similar companies

Companies in the same industry as Viatris, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.

CompanyShare buybacks, latest yearYear ended
Royalty Pharma$1.2BDec 31, 2025
United Therapeutics$1BDec 31, 2025
AbbVie$980MDec 31, 2025
Abbott Laboratories$893MDec 31, 2025
Viatris$500MDec 31, 2025
Corcept Therapeutics$173MDec 31, 2025
Prestige Consumer Healthcare$156MMar 31, 2026

Questions and answers

What is Viatris's share buybacks?

Viatris spent $500M buying back its own shares in the year ended Dec 31, 2025, up 100.2% from $250M a year earlier.

Numbers as reported in Viatris's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology